Predictions
Trillium Therapeutics
Start price
Target price
Perf. (%)
€8.28
07.09.20
07.09.20
-
04.11.21
04.11.21
-21.91%
15.07.21
15.07.21
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.25
30.07.20
30.07.20
-
04.11.21
04.11.21
-13.08%
15.07.21
15.07.21
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.75
19.11.20
19.11.20
€2.90
19.11.21
19.11.21
-11.05%
10.07.21
10.07.21
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.26
12.06.21
12.06.21
€1.00
12.06.22
12.06.22
-14.11%
26.06.21
26.06.21
Aptose Biosciences
Start price
Target price
Perf. (%)
€4.64
01.05.21
01.05.21
€4.50
01.05.22
01.05.22
-30.60%
11.06.21
11.06.21
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€10.48
25.02.21
25.02.21
-
25.02.22
25.02.22
-18.82%
04.05.21
04.05.21
Aptose Biosciences
Start price
Target price
Perf. (%)
€5.50
24.03.21
24.03.21
€5.50
24.03.22
24.03.22
-15.64%
01.05.21
01.05.21
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.19
08.08.20
08.08.20
€23.20
04.11.21
04.11.21
200.33%
26.03.21
26.03.21
Aptose Biosciences
Start price
Target price
Perf. (%)
€5.50
12.01.20
12.01.20
-
04.11.21
04.11.21
0.00%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
CRH Medical Corp
Start price
Target price
Perf. (%)
€3.22
08.02.21
08.02.21
€3.00
08.02.22
08.02.22
-0.62%
22.02.21
22.02.21
Good culture
Probably not worthwhile Investment
Little innovation
No uniques
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.99
15.01.21
15.01.21
-
4.50%
05.02.21
05.02.21
Risky Investment
Trillium Therapeutics
Start price
Target price
Perf. (%)
€11.70
02.10.20
02.10.20
-
04.11.21
04.11.21
-14.10%
10.12.20
10.12.20
Oncolytics Biotech
Start price
Target price
Perf. (%)
€3.10
23.01.20
23.01.20
€12.00
04.11.21
04.11.21
-16.13%
10.12.20
10.12.20
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€60.55
16.11.20
16.11.20
€105.00
16.11.21
16.11.21
-10.40%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.53
28.10.20
28.10.20
€2.10
04.11.21
04.11.21
8.70%
19.11.20
19.11.20
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€2.14
08.09.20
08.09.20
-
04.11.21
04.11.21
-22.43%
13.11.20
13.11.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.14
29.10.20
29.10.20
-
04.11.21
04.11.21
-2.32%
13.11.20
13.11.20
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€57.75
02.11.20
02.11.20
-
04.11.21
04.11.21
-4.85%
13.11.20
13.11.20
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€60.90
01.10.20
01.10.20
-
02.11.20
02.11.20
-5.17%
02.11.20
02.11.20
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.65
22.10.20
22.10.20
-
29.10.20
29.10.20
-4.62%
29.10.20
29.10.20
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€4.40
26.10.20
26.10.20
-
29.10.20
29.10.20
-5.99%
29.10.20
29.10.20